Literature DB >> 32298477

The coxsackievirus and adenovirus receptor: virological and biological beauty.

Katherine J D A Excoffon1,2.   

Abstract

The coxsackievirus and adenovirus receptor (CAR) is an essential multifunctional cellular protein that is only beginning to be understood. CAR serves as a receptor for many adenoviruses, human group B coxsackieviruses, swine vesicular disease virus, and possibly other viruses. While named for its function as a viral receptor, CAR is also involved in cell adhesion, immune cell activation, synaptic transmission, and signaling. Knockout mouse models were first to identify some of these biological functions; however, tissue-specific model systems have shed light on the complexity of different CAR isoforms and their specific activities. Many of these functions are mediated by the large number of interacting proteins described so far, and several new putative interactions have recently been discovered. As antiviral and gene therapy strategies that target CAR continue to emerge, future work poised to understand the biological implications of manipulating CAR in vivo is critical.
© 2020 Federation of European Biochemical Societies.

Entities:  

Keywords:  CAR; PDZ domain; adenovirus; coxsackievirus; gene therapy; protein isoforms; rhesus enteric calicivirus; swine vesicular disease virus

Year:  2020        PMID: 32298477     DOI: 10.1002/1873-3468.13794

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Protection is not always a good thing: The immune system's impact on gene therapy.

Authors:  Martiela Vaz de Freitas; Lariane Frâncio; Laura Haleva; Ursula da Silveira Matte
Journal:  Genet Mol Biol       Date:  2022-07-15       Impact factor: 2.087

Review 2.  Advances in the polymeric delivery of nucleic acid vaccines.

Authors:  Gang Chen; Bowen Zhao; Elena F Ruiz; Fuwu Zhang
Journal:  Theranostics       Date:  2022-05-13       Impact factor: 11.600

3.  Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating.

Authors:  Longfa Xu; Qingbing Zheng; Rui Zhu; Zhichao Yin; Hai Yu; Yu Lin; Yuanyuan Wu; Maozhou He; Yang Huang; Yichao Jiang; Hui Sun; Zhenghui Zha; Hongwei Yang; Qiongzi Huang; Dongqing Zhang; Zhenqin Chen; Xiangzhong Ye; Jinle Han; Lisheng Yang; Che Liu; Yuqiong Que; Mujin Fang; Ying Gu; Jun Zhang; Wenxin Luo; Z Hong Zhou; Shaowei Li; Tong Cheng; Ningshao Xia
Journal:  Cell Host Microbe       Date:  2021-02-03       Impact factor: 21.023

4.  Possible Association of Pulmonary Atresia with In-Utero Coxsackievirus B Exposure.

Authors:  Horacio G Carvajal; Vipul Sharma; Lisa S Goessling; Taylor C Merritt; Anoop K Brar; Pirooz Eghtesady
Journal:  Pediatr Cardiol       Date:  2022-01-12       Impact factor: 1.838

5.  An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer.

Authors:  Li Ding; Qingqing Gao; Zhuobin Xu; Liangliang Cai; Sujuan Chen; Xinyue Zhang; Peng Cao; Gang Chen
Journal:  Adv Sci (Weinh)       Date:  2021-11-07       Impact factor: 16.806

6.  The Coxsackievirus and Adenovirus Receptor Has a Short Half-Life in Epithelial Cells.

Authors:  Poornima Kotha Lakshmi Narayan; James M Readler; Mahmoud S Alghamri; Trisha L Brockman; Ran Yan; Priyanka Sharma; Vladislav Snitsarev; Katherine J D A Excoffon; Abimbola O Kolawole
Journal:  Pathogens       Date:  2022-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.